DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Zensar Technologies Limited — Amalgamation/Merger

NSE 53 min ago·28 Oct 2026, 4:57 pm

Zensar Technologies

Zensar Technologies Limited has announced a proposed amalgamation with its parent company, HCL Technologies. This strategic move aims to combine the two entities into a single legal entity, which will result in Zensar becoming a wholly-owned subsidiary of HCL Technologies.

For investors, this merger is significant as it simplifies the corporate structure and may lead to better resource allocation and operational synergies. It also signals a deepening of the relationship between the two technology firms, potentially enhancing their competitive edge in the market.

Investors should monitor the regulatory approvals and timelines for the completion of this amalgamation. The finalization of this deal is expected to be a key event that could influence the stock's performance in the coming months.